{"product_id":"global-ai-in-medical-imaging-market-size-study-forecast-by-technology-deep-learning-natural-language-processing-nlp-others-by-modality-ct-scan-mri-x-rays-ultrasound-nuclear-imaging-by-application-neurology-respiratory-and-pulmonary-card","title":"Global AI In Medical Imaging Market Size study \u0026 Forecast, by Technology (Deep Learning\nNatural Language Processing (NLP), Others), by Modality (CT scan, MRI, X-rays, Ultrasound, Nuclear Imaging), by Application (Neurology, Respiratory and Pulmonary, Card","description":"\u003cp\u003eGlobal AI In Medical Imaging Market Size study \u0026amp; Forecast, by Technology (Deep Learning Natural Language Processing (NLP), Others), by Modality (CT scan, MRI, X-rays, Ultrasound, Nuclear Imaging), by Application (Neurology, Respiratory and Pulmonary, Cardiology, Breast Screening, Orthopedics, Others), by End-User (Hospitals, Diagnostic Imaging Centers, Others), and Regional Analysis, 2022-2029\u003c\/p\u003e\n\n\u003cp\u003eGlobal AI In Medical Imaging Market is valued at approximately USD 562.2 million in 2021 and is anticipated to grow with a healthy growth rate of more than 34.7% over the forecast period 2022-2029. AI In Medical Imaging is refers as a diagnostic procedure that uses use of Artificial Intelligence (AI) technology to enhance medical screenings, improve precision medicine, and assess patient risk factors. This technology helps in creating visual aids and images that illustrate the human body and includes monitoring the performance and functioning of the organs of the human body. The growing imaging volumes, increasing government initiatives to drive AI-based technologies, and rise in incidence of chronic diseases are prominent factors that are bolstering the market demand across the globe.\u003c\/p\u003e\n\n\u003cp\u003eThe rising adoption of Artificial intelligence (AI) in healthcare industry is exhibiting a positive influence on the growth of the market. According to the Statista analysis, in 2021, the global market for Artificial intelligence (AI) in healthcare was estimated to be worth around USD 11.06 billion. In addition, it is projected that the market grows and reached  USD 38.66 billion by 2025 and USD 187.95 by 2030. Consequentially, the rapid integration of AI in the healthcare industry is acting as a catalyzing factor for the growth of the global market. Furthermore, the growing R\u0026amp;D investment, as well as introduction of technologically advancement products are presenting various growth prospects to the market over the foreseen years. However, the high cost and reluctance of adoption of these systems and limited interoperability for AI solutions stifles market growth throughout the forecast period of 2022-2029.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global AI In Medical Imaging Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the availability of technologically advanced infrastructure, along with rise in cross-industry collaborations and partnerships. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing government programs, rising number of startups using artificial intelligence (AI), as well as the growing digitalization in healthcare businesses in the regional market.\u003c\/p\u003e\n\n\u003cp\u003eMajor market players included in this report are:\u003cbr\u003e\nSiemens Healthineers AG\u003cbr\u003e\nGeneral Electric Company\u003cbr\u003e\nKoninklije Philips N.V.\u003cbr\u003e\nIBM Corporation\u003cbr\u003e\nAgfa-Gevaert Group\/Agfa Health Care\u003cbr\u003e\nArterys\u003cbr\u003e\nAZmed\u003cbr\u003e\nCaption Health\u003cbr\u003e\nGleamer\u003cbr\u003e\nButterfly Network Inc.\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\n? In July 2022, Philips SmartSpeed AI-based software its 510(k) received an approval from the FDA. The software offer ground-breaking high-speed and high-resolution MR imaging, which enables quicker and higher-quality scans for almost all patients with a variety of illnesses, including those with implants (97% of clinical protocols).\u003c\/p\u003e\n\n\n\u003cp\u003eGlobal AI In Medical Imaging Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Technology, Modality, Application, End-User, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003cbr\u003e\nCustomization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional \u0026amp; segment scope*\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Technology:\u003cbr\u003e\nDeep Learning\u003cbr\u003e\nNatural Language Processing (NLP)\u003cbr\u003e\nOthers\u003cbr\u003e\nBy Modality:\u003cbr\u003e\nCT Scan\u003cbr\u003e\nMRI\u003cbr\u003e\nX-rays\u003cbr\u003e\nUltrasound\u003cbr\u003e\nNuclear Imaging\u003cbr\u003e\nBy Application:\u003cbr\u003e\nNeurology\u003cbr\u003e\nRespiratory and Pulmonary\u003cbr\u003e\nCardiology\u003cbr\u003e\nBreast Screening\u003cbr\u003e\nOrthopedics\u003cbr\u003e\nOthers\u003cbr\u003e\nBy End-User:\u003cbr\u003e\nHospitals\u003cbr\u003e\nDiagnostic Imaging Centers\u003cbr\u003e\nOthers\u003cbr\u003e\nBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRoLA\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\n\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eSiemens Healthineers AG\u003cbr\u003e\nGeneral Electric Company\u003cbr\u003e\nKoninklije Philips N.V.\u003cbr\u003e\nIBM Corporation\u003cbr\u003e\nAgfa-Gevaert Group\/Agfa Health Care\u003cbr\u003e\nArterys\u003cbr\u003e\nAZmed\u003cbr\u003e\nCaption Health\u003cbr\u003e\nGleamer\u003cbr\u003e\nButterfly Network Inc.\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 200 Pages \/ MCW16235166","offer_id":47651145941298,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-ai-in-medical-imaging-market-size-study-forecast-by-technology-deep-learning-natural-language-processing-nlp-others-by-modality-ct-scan-mri-x-rays-ultrasound-nuclear-imaging-by-application-neurology-respiratory-and-pulmonary-card","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}